S8 Ep2: Exploring AI Innovation: insitro CEO Daphne Koller On AI In Drug Discovery
Update: 2025-03-05
Description
Dean Lloyd Minor welcomes Daphne Koller, PhD, founder and CEO of insitro, for a conversation about AI’s potential to transform drug discovery. They discuss how machine learning algorithms can accelerate the drug design process, quickly identifying biological patterns and predicting outcomes. They also explore the challenges and opportunities of founding a startup in Silicon Valley, and how insitro’s collaborations with large pharmaceutical companies are advancing therapeutics for Amyotrophic lateral sclerosis (ALS) and other conditions.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
